Trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix

Trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix has been studied in 1 paper since 2024: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Aug 9, 2024: “Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Canada First Research Excellence Fund and 3 more
  • Animals1

What did studies of trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix find?

2

Studies of trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix measured 2 outcomes: influenza and immune response.

Influenza

downin mice1

1 study
  1. Trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix protects against influenza in mice (H1N1pdm09-like virus challenge).

    “Overall, TIV-IMXQB improved the immunogenicity compared to TIV by enhancing systemic and mucosal immunity in old mice conferring a faster recovery after the H1N1pdm09-like virus challenge.”

    AnimalsH1N1pdm09-like virus challenge

    Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice

    Vaccines

More on Influenza

Immune response

upin mice1

1 study
  1. Trivalent influenza vaccine + quillaja brasiliensis saponin-based iscom matrix activates immune response in mice.

    “TIV-IMXQB improved the immunogenicity compared to TIV by enhancing systemic and mucosal immunity in old mice”

    Animalsintranasal and subcutaneous

    Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice

    Vaccines

More on Immune response

Latest